Welcome to our dedicated page for Addus Homecare SEC filings (Ticker: ADUS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Addus HomeCare Corporation filings document a home care provider with personal care, hospice and home health operations. Form 8-K reports furnish quarterly and annual results of operations, Regulation FD disclosures and exhibit press releases, while amended 8-K filings provide acquisition-related financial statements and pro forma information for the completed purchase of Gentiva's personal care business by Addus HealthCare, a wholly owned subsidiary.
Proxy and annual-meeting filings cover board elections, auditor ratification, executive compensation votes and related governance disclosures. The filing record also includes capital-structure, material-event and shareholder-vote disclosures for the company's common stock.
Addus HomeCare Corp executive Roberton James Stevenson reported two open-market sales of common stock under a pre-set 10b5-1 plan. He sold 567 shares on February 24, 2026 at $107.35 per share and 284 shares on February 25, 2026 at $105.36 per share to cover tax obligations from vesting restricted stock awards. After these transactions, he directly holds 14,030 shares.
Addus HomeCare Corp executive Cliff Donald Blessing reported open-market sales of company stock. He sold 350 shares on February 24 at $107.14 per share and 177 shares on February 25 at $105.36 per share. These transactions were made under a previously established Rule 10b5-1 trading plan to satisfy tax obligations from vesting restricted stock awards. After these sales, he directly owns 12,361 common shares.
Addus HomeCare Corp executive Michael D. Wattenbarger, EVP and Chief Information Officer, reported selling 892 shares of common stock in two open-market transactions. He sold 592 shares at $107.35 per share and 300 shares at $105.36 per share, all classified as direct ownership.
According to the filing, these sales were made under a previously established Rule 10b5-1 trading plan and were undertaken to satisfy tax obligations arising from the vesting of restricted stock awards granted by Addus. After these transactions, Wattenbarger directly holds 9,444 shares of Addus common stock.
Addus HomeCare Corp executive David W. Tucker reported selling company stock in two open-market transactions. As EVP and Chief Strategy Officer, he sold 704 shares of common stock on February 24 at $107.35 per share and 379 shares on February 25 at $105.36 per share.
These sales, totaling 1,083 shares, were made pursuant to a previously established Rule 10b5-1 trading plan to satisfy tax obligations arising from the vesting of restricted stock awards granted by Addus. Following the most recent sale, Tucker directly holds 10,423 shares of Addus common stock.
Addus HomeCare Corp executive Anderson Darby reported small planned stock sales under a Rule 10b5-1 plan. On February 24, 2026, Darby sold 733 shares of common stock at an average price of $106.98, followed by 396 shares at $105.36 on February 25, 2026. The footnotes state these sales were made under a previously established 10b5-1 plan to cover tax obligations from vesting restricted stock awards. After these transactions, Darby directly owned 46,246 shares of Addus HomeCare common stock.
Addus HomeCare Corp executive Sean Gaffney, EVP and Chief Legal Officer, reported selling 1,259 shares of common stock in open-market transactions under a previously established Rule 10b5-1 trading plan.
The sales occurred on February 24 and 25, 2026, at prices of $106.98 and $105.36 per share. According to the disclosure, the trades were made to satisfy tax obligations arising from the vesting of restricted stock awards. After these transactions, Gaffney directly owned 20,080 shares of Addus common stock.
Addus HomeCare Corp EVP and CFO Brian Poff reported open-market sales of 2,861 shares of common stock. The transactions occurred on two days, involving 2,041 shares on one day and 820 shares on the next, at prices a little above $105 per share. According to the footnotes, these sales were executed under a previously established Rule 10b5-1 trading plan and were made to cover tax obligations arising from the vesting of restricted stock awards. After these sales, Poff continues to hold 63,692 shares of Addus HomeCare common stock directly.
Addus HomeCare Corp Chairman and CEO Dirk Allison reported selling a total of 7,352 shares of common stock in open-market transactions. He sold 4,988 shares at an average price of $106.98 on February 24 and 2,364 shares at $105.36 on February 25. These sales were made under a previously established Rule 10b5-1 trading plan to cover tax obligations from vesting restricted stock awards. After the transactions, he directly owns 183,150 shares of Addus HomeCare common stock.
Addus HomeCare Corporation reports strong expansion as a multi-segment home care provider focused on personal care, hospice and home health services. For the year ended December 31, 2025, total net service revenue rose to $1,422,530,000 from $1,154,599,000, while net income increased to $95,910,000 from $73,598,000.
The company served about 107,000 consumers across 23 states through roughly 262 offices, with a model centered on mostly dual-eligible Medicare/Medicaid patients and growing relationships with managed care organizations. Growth comes from both organic initiatives and acquisitions; six deals completed in 2024–2025 added meaningful revenue. Addus highlights opportunities from aging demographics, home- and community-based services demand and industry consolidation, while also warning about significant regulatory, Medicaid funding, labor cost and macroeconomic risks that could pressure margins and growth.
Addus HomeCare Corp executive Monica Raines reported both a stock award and a small sale of shares. On February 20, 2026, she acquired 2,858 shares of common stock as a grant at $0.00 per share, vesting in three equal installments on February 20, 2027, February 20, 2028, and February 20, 2029, subject to continued service and change-in-control provisions.
On February 23, 2026, she sold 446 shares of common stock in an open-market transaction at an average price of $114.91 per share under a previously established Rule 10b5-1 trading plan to satisfy tax obligations from restricted stock vesting. After these transactions, she directly held 14,457 shares of Addus common stock.